Tunicamycin treatment of radioactively labelled infected Vero cells followed by electrophoresis in polyacrylamide gels showed that the mol. wt. of the putative polypeptide backbones of GP59(E1) and GP43(E2), the intracellular counterparts to the envelope proteins E 1 and E2 of rubella virus, were 53 000 and 34000, respectively. Two possible intermediates in the glycosylation of GP43(E2) were also identified.
Rubella virus (RV) is an enveloped, single-stranded RNA virus and is the only member of the Rubivirus genus in the family Togaviridae (Matthews, 1982) . Recent studies on the structural proteins of RV indicate that it contains a core protein C (mol. wt. 33000 to 38000) and two glycosylated envelope proteins, E 1 (mol. wt. 55 000 to 62 000) and a heterogeneous E2 (mol. wt. 42 000 to 54 000) that may be composed of two or more related glycoproteins (Ho-Terry & Cohen, 1982; Oker-Blom et al., 1983; Toivonen et al., 1983; Waxham & Wolinsky, 1983; Bowden & Westaway, 1984) . The intracellular counterparts to the structural proteins were recently identified (Oker-Blom et al., 1983; Bowden & Westaway, 1984) and we designated them GP59(E1), GP43(E2) and C. In polyacrylamide gels, the electrophoretic mobility of intracellular C and of GP59(E1) was similar to that of the corresponding virion proteins; GP43(E2) also migrated as a discrete band but virion E2 migrated more slowly as a broad diffuse band probably because of glycosylation differences. Recent reports on the carbohydrate components of RV-specified proteins (Oker-Blom et al., 1983 ; Toivonen et al., 1983 ; Bowden & Westaway, 1984) have been confined to the virion glycoproteins and have not included any glycopeptide analysis. In this report we examine the glycosylation of GP59(E1) and GP43(E2) and describe the glycopeptides detected after Pronase digestion of E1 and E2 and their intracellular counterparts.
Vero cells were infected with RV for preparation of labelled cells and structural proteins as previously described (Bowden & Westaway, 1984) . Proteins were separated in polyacrylamide gels (Laemmli, 1970) and slab gels were processed for fluorography (Bonner & Laskey, 1974) . GP59(E1) and GP43(E2) were readily resolved by electrophoresis when labelled with [3H]mannose (Fig. l a, lane 2) whereas radioimmunoprecipitation was required when [35S]methionine was employed as label ( Fig. 1 b, lane 4 ; Bowden & Westaway, 1984) . E1 and E2 were detectably labelled with [3H]galactose (Fig. i a, lane 5) , whereas GP59(E1) and GP43(E2) were not (results not shown). As noted above, E1 migrated as a sharp band and E2 as a diffuse band (Fig. 1 a, lanes 3 and 5) ; in one preparation only, E2 was resolved into more distinct upper and lower regions (Fig. 1 a, lane 4) analogous to E2a and E2b reported by Oker-Blom et al. (1983) . The distribution of label within the E2 band suggested that it is composed of at least two The procedure used for radioimmunoprecipitation has been previously described (Bowden & Westaway, 1984) . Cells were pretreated for 3 h from 42 h after infection with tunicamycin and labelled for 1 h with 100 laCi/ml [3sS]methionine. Lanes 1 to 3 and 4 to 6 are mockinfected and infected cell extracts respectively, treated with 0 (lanes 1 and 4), 1 (lanes 2 and 5) and 2 (lanes 3 and 6) rtg/ml tunicamycin. As noted previously (Bowden & Westaway, 1984) , two minor proteins apparently of host origin migrated between GP59(E1) and GP43(E2). The unglycosylated forms of GP59 (E1) glycoproteins, the faster and slower migrating components containing high-mannose glycans and complex glycans, respectively (Oker-Blom et al., 1983; Bowden & Westaway, 1984) . Treatment of RV-infected cells with 1 or 2 ~tg/ml tunicamycin prevented glycosylation and enabled identification of the putative polypeptide backbones of GP59(E1) and GP43(E2) in [35S]methionine-labelled cytoplasm ( Fig. 1 b, lanes 5 and 6); their mol. wt. estimates were 53 000 and 34000, respectively. If these are the polypeptide backbones, GP43(E2) has a significantly greater carbohydrate content than GP59(E 1). Similar results using a single dose of tunicamycin and [35S]methionine as label were obtained by Oker-Blom et al. (1983) . To show whether the putative polypeptide backbones were devoid of carbohydrate, we labelled infected cells with [3H]mannose in the presence of 0.5 and 1 I.tg/mt tunicamycin. No [3H]mannose-labelled products of mol. wt. 53000 and 34000 were seen, but two possible intermediates in the synthesis of GP43(E2) were detected ( Fig. 1 c, lanes 2 and 3) (E1) were detected after tunicamycin treatment. These results indicate either that one of the glycans to be added to the polypeptides of both GP59(E1) and GP43(E2) must be unusually large (tool. wt. 5000 to 6000), or that smaller intermediates appeared too transiently to be detected using [3H]mannose as label. (Our glycopeptide data in Fig. 2 show that the latter is more likely.) Attempts to label any of these glycosylated intermediates with [35S]methionine using doses of 0-1 to 2 ~tg/ml tunicamycin were unsuccessful (results not shown).
The virion glycoproteins and their intracellular counterparts labelled with [3H]mannose were separated in column gels and the proteins were eluted with 0-1~ SDS (Wright et al., 1980) . Samples were dialysed against 0-1 M-ammonium acetate pH 8-0 before digestion with Pronase CB (Calbiochem) as described by Sefton & Keegstra (1974) . The resulting glycopeptides were analysed by gel filtration using a 0-9 x 88 cm column of Bio-Gel P-6 (200 to 400 mesh) and an elution buffer of 0-1 M-ammonium acetate pH 8.0 (Fig. 2) . The sizes of the RV glycopeptides were estimated using the glycopeptides of ovalbumin (tool. wt. 1500) and thyroglobulin (mol. wt. 4100), together with stachyose as mol. wt. markers to calibrate the column (Wright et al., 1980) . The glycopeptides from GP59(E 1), GP43(E2), E 1 and E2 separated into several size groups; two of the size groups common to all glycoproteins eluted as peaks at fractions 45 and 39 ( Fig. 2a to  d) . The mol. wt. estimates of these RV glycopeptides are 1.5K (designated R1.5) and 2.1K (R2.1), respectively. Intracellular GP43(E2) and virion E2 yielded additional glycopeptide(s) at fraction 35 (Fig. 2b, d) , with an estimated mol. wt. of 2.7K (R2.7). The glycopeptides R2.1 derived from El, and R2.7 from E2, were heterogeneous because in four virion preparations, a relatively broad shoulder of higher mol. wt. eluted ahead of each peak as in Fig. 2(c, d) . Each shoulder apparently represents larger glycopeptide(s) because in the analysis of two other virion preparations, a discrete peak eluted at fraction 35 for E1 (mol. wt. 2-7K, R2.7) and fraction 32 for E2 (mol. wt. 3.3K, R3.3) rather than as a shoulder (results not shown).
The combined mol. wt. estimates of the glycopeptides from each of the intracellular glycoproteins (Fig. 2a, b) are not sufficient to account for the faster migration in gels of the putative polypeptide backbones of GP59(E1) and GP43(E2) compared to that of their fully glycosylated forms (Fig. 1 b) . Therefore, it seems likely that one or more glycopeptides of similar mol. wt. eluted at the same position, represented in each case by a single peak. The two partially glycosylated intermediates of GP43(E2) detected after tunicamycin treatment of [3H]mannoselabelled cells (Fig. 1 c, lanes 2 and 3) may lack glycans contained in glycopeptides from the R2.7 and R2.1 size groups detected in the elution profiles of GP43(E2) (Fig. 2b) .
Mild acid hydrolysis (Sefton & Keegstra, 1974) of individual glycopeptide peaks from each glycoprotein had no effect on their elution position, indicating that sialic acid was absent or in very low amounts (results not shown). This result, together with the detection of [3H]galactose in E1 and E2, is consistent with the findings of Toivonen et al. (1983) who showed that E1 and E2 contained galactose rather than sialic acid as the terminal carbohydrate. The lack of incorporation of [3H]galactose into GP59(E1) and GP43(E2) and the differences in elution profiles between the intracellular and virion glycopeptides (Fig. 2 , compare a and b with c and d) suggest that some late modification of the glycans, such as conversion of high-mannose glycans to complex glycans, occurs in G P59(E 1) and GP43(E2) before they are incorporated into virions as E1 and E2. To investigate this possibility, each glycopeptide peak was digested with 5 milliunits of endo-fl-N-acetylglucosaminidase H (endo H; Seikagaku Kogyo, Tokyo, Japan), at 37 °C for 16 h in 0-05 M-sodium citrate pH 5.1. Endo H cleaves mannose-rich glycans between the two N-acetylglucosamine residues adjacent to the covalently linked asparagine, whereas complex glycans remain resistant (Tarentino et al., 1974) . Analysis of each of the glycopeptide peaks of GP59(E1) and GP43(E2) after endo H digestion showed a uniform shift of radioactivity to a lower mol. wt. position (results not shown), indicating they were sensitive, whereas analysis of the glycopeptides of E1 and E2 after endo H digestion revealed both sensitive and resistant species (Fig. 2e, f) . Only the smallest glycopeptide peak (R1.5) of E1 and E2 was completely sensitive to endo H ( Fig. 2e ; in 2f the residual peak has not been included to simplify presentation), indicating that it probably contains only high-mannose or simple glycans. The (Pharmacia) and the mol. wt. of the internal marker, calculated to be 2100 from our mol. wt. markers, corresponds to the value determined by Stenvall & Renkonen (1979) . elution positions of the largest glycopeptides of El and E2, R2.7 and R3.3 respectively, were unaffected by endo H treatment, indicating that they contained complex giycans. Of the remaining size classes, i.e. R2.1 of the E1 glycopeptides and R2.1 and R2.7 of the E2 glycopeptides, endo H digestion caused a shift of about 50~o of the label to a lower mol. wt. region (Fig. 2e, f) , showing that these peaks probably contain both high-mannose and complex glycans. In contrast, Oker-Blom et al. (1983) suggested that the glycans of E1 and E2 were all of the resistant type because the mobility of the glycoproteins in their gels was unaffected following endo H treatment. However, their method is probably less sensitive than is the digestion of individual glycopeptides with endo H, although the possibility of virus strain variation cannot be excluded.
Our conclusion, that during the maturation of E 1 and E2 some of the high-mannose glycans in GP59(E1) and GP43(E2) are converted to complex glycans apparently by loss of mannose and incorporation of other carbohydrates, is in conformity with results of our previous analyses on the distribution of carbohydrates in E 1 and E2 and justifies our distinctions in nomenclature of the intracellular counterparts (Bowden & Westaway, 1984) . Alternatively, an undetected population of intracellular glycoproteins with some complex glycans may be incorporated preferentially into virions as E1 and E2. The changes during maturation are greater for E2 than El. The change in proportion of [3H]mannose label in the high-mannose glycans of R1.5 and R2.1 of GP43(E2) (Fig. 2b) to that in the complex glycans of R2.7 and R3.3 of E2 (Fig. 2d) is larger than expected because complex glycans contain relatively few mannose residues compared to high-mannese glycans (Kornfeld & Kornfeld, 1980) . This shift may represent significant changes in the glycan moieties and it may be related to the observed heterogeneity of E2 in gels. The probable site of maturation of E 1 and E2 is within the Golgi membranes which undergo proliferative changes prior to budding of virions within their vicinity (Holmes et al., 1969; von Bonsdorff & Vaheri, 1969) . Despite some strong similarities to those of the alphaviruses (Oker-Blom et al., 1983 ; Bowden & Westaway, 1984) , the envelope glycoproteins of RV contain a larger proportion of carbohydrate, e.g. tool. wt. 6000 in GP59(E1) and El, and 9000 to 14000 in GP43(E2) and E2, compared to a carbohydrate content of mol. wt. 4000 only in both E1 and E2 of Sindbis virus (Sefton & Keegstra, 1974) . Furthermore, high-mannose glycans are found exclusively only in PE2, the precursor of alphavirus E2 (Sefton & Keegstra, 1974; Stenvall & Renkonen, 1979) . Hence, although the structural proteins of alphaviruses and RV are translated as a polyprotein from a subgenomic mRNA of similar size (Oker-Blom et al., 1984) , it is clear that the envelope glycoproteins of RV undergo more significant changes during maturation than do those of the alphaviruses.
